Can exercise protect diabetic joints? new study investigates
NCT ID NCT04893135
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how quickly bringing high blood sugar under control, combined with moderate treadmill walking, affects certain proteins linked to bone health in people with type 2 diabetes. The goal was to understand why some patients develop a rare but serious joint condition called Charcot neuroarthropathy. Sixty adults with poorly controlled diabetes participated, and researchers measured changes in the RANKL/OPG system, which regulates bone turnover.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- treadmill walking
- What this could lead to
- If successful, this could help explain why some diabetes patients develop joint problems, potentially pointing to ways to prevent it.
- What could go wrong
- This is a small, completed observational study with only 60 participants. It measures biological markers, not direct health outcomes, so results may not lead to clear treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Oct 2021
- Finished
-
Oct 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Group G1: * Male or female patient aged 18 to 70, not practicing regular physical activity (Baecke score \<10) * Patient with type 2 diabetes for at least 1 year * Patient treated with metformin +/- SU +/- DPP4 inhibitor +/- GLP1 analogue +/- insulin therapy * Patient insufficiently balanced under his current treatment with an HbA1c level\> 8.5% for 6 months. * Patient able to practice physical activity on a regular basis * Patient having performed a coronary artery disease screening test in the year prior to inclusion * Woman of childbearing age with effective contraception put in place and monitored throughout the trial * Patient having given his consent to participate in the study and having signed an informed consent * Within the G1 group, a controlled 1: 1 randomization, stratified on age (≤65 years or\> 65 years) and BMI (≤ 30 or\> 30) will determine the inclusion of patients in the G1A group (correction of HbA1c) or G1B (correction of HbA1c + physical activity). Group G2: * Male or female patient aged 18 to 70, not practicing regular physical activity * Patient with type 2 diabetes for at least 1 year * Patient treated with metformin +/- SU +/- DPP4 inhibitor +/- GLP1 analogue +/- insulin therapy * Patient balanced under his current treatment with an HbA1c level \<7% for 6 months. * Women of childbearing potential with effective contraception put in place and monitored throughout the trial * Patient having given his consent to participate in the study and having signed an informed consent * Matching with the last patient included in group G1 on age (± 5 years), sex, duration of diabetes (± 2 years) and BMI (± 2kg / m2). Exclusion Criteria: * Fetal and maternal pathologies requiring maturation Patient with type 1 diabetes * Patient with regular physical activity * History of severe cardiovascular pathologies (myocardial infarction, or acute coronary syndrome, or stroke in the past year) * Patient with a history of severe hypoglycemia in the 6 months preceding entry into the study and / or not experiencing hypoglycemia at all * Patient pregnant or likely to be * Severe obesity (BMI\> 35kg / m2) * Other pathologies likely to interfere with the glycemic variation: in particular the use of corticosteroids during the study * Patient already having Charcot's neuroarthropathy or symptomatic autonomic neuropathy: orthostatic hypotension and / or gastro-paresis * Patient with preproliferative diabetic retinopathy * Patient having anti RANKL treatment * Subject under tutorship or curatorship * Subject not affiliated to social security.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91100, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Gut microbes in pregnancy and infancy: a window into lifelong health?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Chatbot coach takes aim at diabetes risk after pregnancy